The Use of MCDA for HTA Agencies – Options, Limitations and the Way Forward

April 3, 2019
11:00AM EDT | 4:00PM GMT | 5:00PM CEST- 1 hour in duration
Click here for time zone conversion

Speaker: Rob Baltussen, PhD

Recent years have witnessed an increased interest in the use of multi-criteria decision analysis (MCDA) to improve the quality, consistency, and transparency of priority setting in health care. However, the use of MCDA for health technology assessment (HTA) agencies has been criticised as being “entirely mechanistic”. This webinar presents the debate on the use of MCDA in HTA decision-making. Baltussen presents a recent paper, co-authored by 25 MCDA-experts, including a typology of MCDA studies, a review of studies over the period 1990-2017, and a critical assessment of the various study types on their relevance for HTA agencies.

Learning Objectives:

  • Discuss the difference between 'qualitative MCDA', 'quantitative MCDA' and 'MCDA with decision rules'
  • Describe the limitations of especially 'quantitative MCDA'
  • Explain how MCDA can be best used in the future?

This webinar is complimentary for members and non-members.
If you would like to participate in this webinar,
be sure to register via the link provided below!

Register Here


This webinar is brought to you by:



Rob Baltussen, PhD
Department for Health Evidence
Radboud University
Nijmegen Medical Center
Nijmegen, Netherlands

Please note: On the day of the scheduled webinar, the first 500 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 weeks after the scheduled Webinar.

Reservations are on a first-come, first-served basis for all ISPOR members.

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now